Angenerico

Angenerico was the generic pharmaceutical division of the Italian healthcare group Angelini Industries (Angelini Pharma). Operating primarily in Italy and Spain, the company specialized in the production and distribution of high-quality generic medicines across several therapeutic categories, including central nervous system (CNS) disorders and pain management. Its portfolio featured generic versions of widely used drugs such as olanzapine, ketoprofen, and diclofenac. Following a strategic reorganization by its parent company, Angenerico entered liquidation in the early 2020s, with its operations being absorbed or phased out as Angelini shifted focus toward branded specialty medicines and brain health.